Newmarket Biomedical Ltd

Newmarket Biomedical Ltd is a British in-vitro diagnostic (IVD) reagents and test kits manufacturer established in 2011. The company specializes in the worldwide manufacture, sale, and distribution of diagnostic kits and laboratory products, with particular expertise in syphilis serology testing. Core product lines include RPR (rapid non-treponemal particle agglutination) tests, TPHA (passive particle agglutination assays for Treponema pallidum detection), Syphilis EIA Total Antibody tests, and bulk reagents available upon request. Newmarket Biomedical holds ISO 13485 and MDSAP certifications, with QMS recertification valid until 2027. The company is IVDR-compliant for TPHA and RPR kits, demonstrating adherence to EU in-vitro diagnostic regulations. Products are distributed globally across the UK, USA, Canada, EU, India, Australia, Vietnam, Philippines, South Africa, and other territories. The company maintains quality assurance and regulatory compliance standards suitable for clinical laboratory, research, and diagnostic applications.